C a Boucher - JoVE Visualize

Showing results (201-210 of 254) with videos related to

Pageof 26

Sort By:

Antiviral Therapy|April 1, 1997

HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrierD M Burger, C A Boucher, P L Meenhorst, et al.

American Heart Journal|December 1, 1986

Anterior ST segment depression in acute inferior myocardial infarction as a marker of greater inferior, apical, and posterolateral damageT D Ruddy, T Yasuda, H K Gold, et al.

The Journal of Antimicrobial Chemotherapy|February 14, 1998

In-vitro selection of HIV-1 variants resistant to non-nucleoside reverse transcriptase inhibitors in monocyte-derived macrophagesA M Been-Tiktak, C J de Haas, L de Graaf, et al.

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1997

Vertical HIV-1 transmission correlates with a high maternal viral load at deliveryO Coll, M Hernandez, C A Boucher, et al.

Lancet (London, England)|September 8, 1990

Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapyC A Boucher, M Tersmette, J M Lange, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001

Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistanceJ W Cohen Stuart, A M Wensing, C Kovacs, et al.

Annals of Internal Medicine|June 1, 1989

Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgeryK A Eagle, C M Coley, J B Newell, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000

The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulationJ W Cohen Stuart, M D Hazebergh, D Hamann, et al.

Circulation|May 1, 1983

Exercise testing in asymptomatic or minimally symptomatic aortic regurgitation: relationship of left ventricular ejection fraction to left ventricular filling pressure during exerciseC A Boucher, R A Wilson, D J Kanarek, et al.

Antimicrobial Agents and Chemotherapy|July 1, 1995

Safety, pharmacokinetics, and antiviral activity of A77003, a C2 symmetry-based human immunodeficiency virus protease inhibitorM Reedijk, C A Boucher, T van Bommel, et al.

Pageof 26

Showing results (201-210 of 254) with videos related to

Sort By:

Pageof 26

Antiviral Therapy|April 1, 1997

HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrierD M Burger, C A Boucher, P L Meenhorst, et al.

American Heart Journal|December 1, 1986

Anterior ST segment depression in acute inferior myocardial infarction as a marker of greater inferior, apical, and posterolateral damageT D Ruddy, T Yasuda, H K Gold, et al.

The Journal of Antimicrobial Chemotherapy|February 14, 1998

In-vitro selection of HIV-1 variants resistant to non-nucleoside reverse transcriptase inhibitors in monocyte-derived macrophagesA M Been-Tiktak, C J de Haas, L de Graaf, et al.

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1997

Vertical HIV-1 transmission correlates with a high maternal viral load at deliveryO Coll, M Hernandez, C A Boucher, et al.

Lancet (London, England)|September 8, 1990

Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapyC A Boucher, M Tersmette, J M Lange, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001

Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistanceJ W Cohen Stuart, A M Wensing, C Kovacs, et al.

Annals of Internal Medicine|June 1, 1989

Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgeryK A Eagle, C M Coley, J B Newell, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000

The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulationJ W Cohen Stuart, M D Hazebergh, D Hamann, et al.

Circulation|May 1, 1983

Antimicrobial Agents and Chemotherapy|July 1, 1995

Safety, pharmacokinetics, and antiviral activity of A77003, a C2 symmetry-based human immunodeficiency virus protease inhibitorM Reedijk, C A Boucher, T van Bommel, et al.

Pageof 26